Publication: 4955

Publication: 4955

Dissecting the effect of hormone receptor status in patients with HER2-positive early breast cancer: exploratory analysis from the ALTTO (BIG 2-06) randomized clinical trial.

PubMed

DOI

Google Scholar

Citation:: Breast Cancer Res Treat vol 177 (1) 103-14

Year:: 2019
Type:: Manuscript
Funding:: NCTN
Endpoint:: Secondary-not-in-original
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: ppub

Note:

Methodological:: No
Biospecimen:: No
SDC:: No
Book Volume:

Parents:: None
Children:: None

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: GlaxoSmithKline (until January 2015), Novartis Pharma AG (as of January 2015)
Grants:: U10CA180821, U10CA180882

Corr. Author:
Authors:: Matteo Lambertini Christine Campbell Richard D Gelber Giuseppe Viale Ann McCullough Florentine Hilbers Larissa A Korde Olena Werner Saranya Chumsri Christian Jackisch Antonio C Wolff Ines Vaz-Luis Arlindo R Ferreira Aleix Prat Alvaro Moreno-Aspitia Martine Piccart Sherene Loi Evandro de Azambuja

Networks:

Study
Multiple Studies, or Legacy Studies in Alliance Study:: NCCTG-N063D
Phases:: 3

Keywords: